Abstract: The invention provides methods for providing Bacillus spores for application to agricultural soil or plant material as well as zootechnic applications for odor control in areas of high ammonia generation. The methods comprise suspending the Bacillus spores in a liquid consisting of water and an organic acid, including acetic acid, wherein the acid lowers the pH so that the spores are inhibited from germination and growth; and so that growth of unwanted microorganisms in the suspension is prevented. Compositions formed according to the methods of the invention are also provided.
Type:
Grant
Filed:
October 20, 2010
Date of Patent:
May 13, 2014
Assignee:
Osprey Biotechnics, Inc.
Inventors:
Christopher J. Reuter, Steven J. MacKenzie
Abstract: The present invention relates to a method for immobilizing enzymes in a solid porous support, and to enzymes immobilized in solid porous supports. Specifically, the present invention uses a fluid containing the enzyme under high pressure (such as 25 to 50 Mpa) to immobilize the enzyme (such as CALB) on the porous support (such as silica). The resulting porous support contain more immobilized enzyme than would otherwise have been obtained by a process carried out at atmospheric pressures.
Type:
Grant
Filed:
March 8, 2005
Date of Patent:
May 6, 2014
Assignee:
Agency for Science, Technology and Research
Abstract: The present invention provides a method of evaluating a patient in a hospital prior to discharge to determine if the patient is or is not at risk of early readmission if the patient were to be discharged from the hospital. The invention also provides a method of evaluating and monitoring the condition of a patient after discharge from a hospital. Both methods comprise measuring the oxidation-reduction potential (ORP) of a body fluid of the patient, a tissue of the patient of both.
Abstract: A method for measuring LAM and a method for detecting an acid-fast bacterium, which comprise at least a step of allowing a Limulus reagent to contact with a LAM-containing sample; a method for removing reactivity of LAM with a Limulus reagent, which comprises at least a step of allowing a predetermined substance to coexist with a LAM-containing sample; a method for measuring Et in a LAM-containing sample and a method for detecting an Et-related disease, which each is a method for measuring an endotoxin using a Limulus reagent, which comprises at least a step of removing reactivity of LAM with a Limulus reagent by the above-described removing method; a method for measuring BG in a LAM-containing sample and a method for detecting mycosis, which is a method for measuring BG using a Limulus reagent, which comprises at least a step of removing reactivity of LAM with a Limulus reagent by the described-described removing method; and the like.
Abstract: A range of concentrations exists in which fermentation inhibitors derived from pretreatment of lignocellulosic feed stocks inhibit growth of lactic acid bacteria without affecting fermentive yeast. By optimizing levels of fermentation inhibitors to fall within this range, yeast fermentations of lignocellulosic biomass can be conducted under non-sterile conditions with ethanol yields comparable to those achieved under sterile conditions. Optimised inhibitor levels can be achieved by controlling the water/biomass ratio of a lignocellulosic biomass during and after pretreatment, for example by washing the fiber fraction of a previously pretreated lignocellulosic biomass with a pre-defined amount of fresh water or recycled process solutions. Crude extracts of liquid fraction or process solutions from pretreatment of lignocellulosic biomass can also provide an effective anti-baterial treatment for first generation starch fermentations.
Abstract: The present disclosure provides devices and rapid methods to acquire a wound sample to detect and measure NOx, and optionally, one or more other analytes that are indicative of the status of a wound.
Type:
Grant
Filed:
August 3, 2010
Date of Patent:
April 22, 2014
Assignee:
3M Innovative Properties Company
Inventors:
Stephanie F. Bernatchez, Vinod P. Menon, Joseph J. Stoffel, Joseph A. Tucker
Abstract: Agents that inhibit or prevent restenosis are identified by assaying test agents in a battery of assays to measure the effect of the test agent on cell proliferation, thrombosis, tissue modeling, and inflammation. Treatment for restenosis is provided using compositions of the invention.
Type:
Grant
Filed:
June 4, 2007
Date of Patent:
April 15, 2014
Assignee:
DiscoverRx Corporation
Inventors:
Eric J. Kunkel, Evangelos Hytopoulos, Ivan Plavec
Abstract: The invention relates to a novel strain of Lactobacillus rhamnosus, having antimicrobial and immunomodulatory properties, and to compositions containing said strain.
Abstract: A method of processing stillage by hydrothermally fractionating stillage to create unique product fractions, by heating the stillage to a temperature of 250 degrees F. to 350 degrees F., and recovering a stickwater fraction from the stillage. Stickwater, oil, biomass, bio-products, extracts, metabolites, and treated water obtained from the method above. A method of performing ethanol fermentation by hydrothermally fractionating stillage to create unique product fractions by heating the stillage to a temperature of 250 degrees F. to 350 degrees F., separating the stillage into a ProFat fraction and a stickwater fraction, and recovering oil from the ProFat fraction.
Type:
Grant
Filed:
April 25, 2013
Date of Patent:
April 15, 2014
Assignee:
Valicor, Inc.
Inventors:
James Robert Bleyer, Thomas J Czartoski, Puneet Chandra
Abstract: Methods for controlling bleeding (e.g., enhancing coagulation and reducing fibrinolysis) in a subject are disclosed. The methods include selecting a subject in need of enhanced coagulation or reduced fibrinolysis, and administering to the subject a carbon monoxide releasing molecule (CORM). Examples of CORMs include tricarbonyldichloro-ruthenium (II) dimer, tricarbonylchloro-(glycinato)ruthenium (II), sodium boranocarbonate, dimanganese decacarbonyl, and iron pentacarbonyl. Further disclosed are compositions and methods for treating a subject in need of a blood product by administering to the subject a composition including a CORM and a blood product (e.g., cryoprecipitate or fresh frozen plasma).
Type:
Grant
Filed:
March 5, 2010
Date of Patent:
April 15, 2014
Assignee:
THe UAB Research Foundation
Inventors:
Vance G. Nielsen, James F. George, James K. Kirklin
Abstract: A method for determining the percentage of live cells or viability of cells in a sample is disclosed. In this method, a cell-containing sample is contacted with hydroxyethyldisulfide and the amount of mercaptoethanol produced is measured. The amount of mercaptoethanol is then compared to reference standard curves to determine the percentage of live cells in the sample or the viability of the cells.
Abstract: The invention relates to a method of purifying PEGylated proteins by removing impurities from samples containing PEGylated proteins, in particular, but not exclusively vitamin K-dependent blood coagulation factors such as Factor IX (FIX), to proteins purified by said method and to the use of said purified proteins in therapy, in particular but not exclusively, for the treatment of diseases alleviated by blood coagulation factors such as the prophylactic treatment of hemophilia.
Type:
Grant
Filed:
November 24, 2010
Date of Patent:
April 15, 2014
Assignee:
Novo Nordisk A/S
Inventors:
Matthias Karl Dietrich Wiendahl, Lars Sejersgaard, Are Bogsnes
Abstract: The present invention provides simple, rapid methods and procedures for analyzing cells, hereunder quantitative and qualitative assessment of cells. The present invention relates to the use of N-(9-acridinyl)maleimide (NAM) or to the use of 7-diethylamino-3-((4?-(iodoacetyl)amino)phenyl)-4-methylcoumarin (CPI), particularly detectable upon its reaction with species (e.g., sulphur-containing species) present in higher concentrations in intact (e.g., living) cells than in non-intact (e.g., dead) cells. The present invention also relates to the use of NAM or to the use of 7-diethylamino-3-((4?-(iodoacetyl)amino)phenyl)-4-methylcoumarin (CPI), particularly detectable upon its reaction with species present in intact and/or non-intact cells. Moreover, the present invention relates to the use of measuring techniques and/or instruments coupled with the use of NAM or with the use of 7-diethylamino-3-((4?-(iodoacetyl)amino)phenyl)-4-methylcoumarin (CPI).
Type:
Grant
Filed:
July 14, 2009
Date of Patent:
April 15, 2014
Assignee:
ChemoMetec A/S
Inventors:
Mette Elena Skindersø, Helle Frobøse Sørensen, Søren Kjaerulff
Abstract: The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria. The treatment method comprises administering a therapeutically effective amount of Lactobacillus acidophilus or one or a combination of a number of other probiotic bacteria to an animal. An alternative treatment method comprises administering a therapeutically effective amount of a lactic acid producing bacterium such as Lactobacillus acidophilus in combination with a lactate utilizing bacterium such as Propionibacterium freudenreichii.
Abstract: The present invention describes an extracellular matrix comprising human platelet derived growth factors, that permits the maximizing of therapeutic efficacy, combining the benefits of both components, to result in a more efficient and rapid integration of the matrix up to the structurally organized reconstruction of the neoformed tissue “in vivo”.
Abstract: Disclosed herein are methods of detecting blood disorders, such as diabetes. In particular examples the method includes contacting a blood sample with an amine reagent, blocking an excess of the amine reagent with a blocking reagent, digesting the modified blood sample with trypsin to produce a digested blood sample containing a plurality of glycated N-terminal peptides and non-glycated N-terminal peptides, then analyzing the digested blood sample with MALDI MS. Also provided are reagents for use in such methods.
Type:
Grant
Filed:
July 7, 2010
Date of Patent:
April 8, 2014
Assignee:
UVic Industry Partnerships Inc.
Inventors:
Evgeniy V. Petrotchenko, Christoph Borchers
Abstract: Methods of producing lignin peroxidase are provided. Also provided are methods and cosmetic compositions suitable for skin and hair lightening as well as kits and an article-of manufacturing including active ingredients for skin and hair lightening.
Type:
Grant
Filed:
May 27, 2008
Date of Patent:
April 8, 2014
Assignee:
R.B.T (Rakuto Bio Technologies) Ltd.
Inventors:
Paula Belinky, Haim Lasser, Carlos Dosoretz
Abstract: It is an object of the present invention to provide a cell culture carrier for producing a cell sheet that can be readily detached from a cell culture carrier and is inhibited from contracting after being detached. The cell culture carrier 1 of the present invention comprises: a support-held culture membrane 4 comprising an organic thin film 2 having cell adhesion properties and biodegradability and a frame-like support 3 fixed on the periphery of the organic thin film for maintaining the dimensions of the organic thin film; and a base substrate 6 having a surface 5 with a static water contact angle of 45° or less, wherein the support-held culture membrane 4 is detachably placed on the surface 5 of the base substrate.
Abstract: Provided is a microarray platform for the culture of cells atop combinatorial matrix mixtures; enabling the study of differentiation in response to a multitude of microenvironments in parallel.
Type:
Grant
Filed:
January 19, 2006
Date of Patent:
April 1, 2014
Assignee:
The Regents of the University of California